Caffeine
- PMID: 30137774
- Bookshelf ID: NBK519490
Caffeine
Excerpt
Caffeine is a naturally occurring central nervous system stimulant belonging to the methylxanthine class and is widely recognized as the most utilized psychoactive stimulant worldwide. Although this drug is most commonly sourced from coffee beans, it can also naturally occur in certain types of tea and cacao beans and as an additive to soda and energy drinks. Caffeine consumption primarily alleviates fatigue and drowsiness but has numerous additional therapeutic applications. The US Food and Drug Administration (FDA) has approved caffeine for treating apnea of prematurity. Off-label uses of caffeine include the treatment of migraines and post-dural puncture headaches, as well as enhancing athletic performance, particularly in endurance sports.
Copyright © 2024, StatPearls Publishing LLC.
Conflict of interest statement
Sections
Similar articles
-
Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters.J Food Sci. 2010 Apr;75(3):R77-87. doi: 10.1111/j.1750-3841.2010.01561.x. J Food Sci. 2010. PMID: 20492310 Review.
-
Just "Like Coffee" or Neuroenhancement by Stimulants?Front Public Health. 2021 Jun 7;9:640154. doi: 10.3389/fpubh.2021.640154. eCollection 2021. Front Public Health. 2021. PMID: 34164365 Free PMC article.
-
Caffeine and Its Antioxidant Properties-It Is All about Dose and Source.Int J Mol Sci. 2022 Oct 28;23(21):13074. doi: 10.3390/ijms232113074. Int J Mol Sci. 2022. PMID: 36361861 Free PMC article. Review.
-
Methylxanthine composition and consumption patterns of cocoa and chocolate products.Prog Clin Biol Res. 1984;158:149-78. Prog Clin Biol Res. 1984. PMID: 6396642 Review.
-
Beliefs, Behaviors, and Contexts of Adolescent Caffeine Use: A Focus Group Study.Subst Use Misuse. 2017 Jul 29;52(9):1207-1218. doi: 10.1080/10826084.2017.1302957. Epub 2017 Jun 12. Subst Use Misuse. 2017. PMID: 28605229
References
-
- Mathew OP. Apnea of prematurity: pathogenesis and management strategies. J Perinatol. 2011 May;31(5):302-10. - PubMed
-
- Schmidt B. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial. Biol Neonate. 2005;88(3):208-13. - PubMed
-
- Klompas M, Branson R, Cawcutt K, Crist M, Eichenwald EC, Greene LR, Lee G, Maragakis LL, Powell K, Priebe GP, Speck K, Yokoe DS, Berenholtz SM. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2022 Jun;43(6):687-713. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources